Magic Mushroom Drug Lifted Depression/Anxiety in Cancer Patients
A new study, published in the Journal of Psychopharmacology on Thursday, has shed new light on psilocybin (magic mushrooms) as a possible anti-anxiety and antidepressant therapy in patients with cancer. The study, which was led by researchers at NYU Langone Medical Center, reportedly saw patients respond to psilocybin to ease their anxiety and depression. Similar findings also were found in a separate study conducted at Johns Hopkins University. For the nine-month study conducted at NYU Langone Medical Center: 29 patients had cancer-related anxiety and depression. Half the participants were given either a single dose of psilocybin or a vitamin...
Read More






